Aspirin in DVT

Phase 3

Recruiting

• Conditions: Deep Vein Thrombosis.; Acute embolism and thrombosis of deep veins of lower extremity; I82.4

• Registration Number: IRCT20200202046344N1
• Lead Sponsor: Tehran University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 6 October 2020

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 446

Inclusion Criteria

Male and Females between 14 and 85 years old
Tibial fractures with or without surgery indication

Exclusion Criteria

Hip or femur fracture
Major fracture except tibia
DVT or PTE history
Low platelet levels (lower than 100,000)
Gustilo type 3B and higher open fractures
Patients that have contraindication to use Aspirin or Heparin
Patients that avoid to participate in the study
Patients with chronic kidney disease that have lower GFR than 30

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Incidence of deep vein thrombosis in lower extremity. Timepoint: At the end of first week, fourth week, 12th week, and 24th week after discharge. Method of measurement: Physical examinations an doppler ultra sonography.

Secondary Outcome Measures

Name	Time	Method
Peptic ulcer disease. Timepoint: At the end of first week, fourth week, 12th week, and 24th week after discharge. Method of measurement: Short questionnaire with 10 questions.